|
🐜
|
The mutational landscape of human somatic and germline cells
28 auth.
L. Moore,
A. Cagan,
Tim H. H. Coorens,
M. Neville,
R. Sanghvi,
M. Sanders,
Thomas R. W. Oliver,
D. Leongamornlert,
P. Ellis,
A. Noorani,
T. Mitchell,
T. Butler,
Y. Hooks,
A. Warren,
M. Jorgensen,
...
K. Dawson,
A. Menzies,
L. O’Neill,
Calli Latimer,
Mabel J Teng,
R. van Boxtel,
C. Iacobuzio-Donahue,
I. Martincorena,
R. Heer,
P. Campbell,
R. Fitzgerald,
M. Stratton,
R. Rahbari
|
7 |
2020 |
7
🐜
|
|
🐜
|
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.
12 auth.
E. Clark,
A. Coulson,
Caroline Dalgliesh,
P. Rajan,
S. Nicol,
S. Fleming,
...
R. Heer,
L. Gaughan,
H. Leung,
D. Elliott,
F. Fuller-Pace,
C. Robson
|
7 |
2008 |
7
🐜
|
|
🐜
|
A Unifying Theory of Branching Morphogenesis
8 auth.
É. Hannezo,
C. Scheele,
M. Moad,
Nicholas Drogo,
R. Heer,
R. Sampogna,
...
J. van Rheenen,
B. Simons
|
7 |
2017 |
7
🐜
|
|
🐜
|
Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer
9 auth.
A. McKie,
David A Douglas,
Sharon Olijslagers,
J. Graham,
M. Omar,
R. Heer,
...
V. Gnanapragasam,
C. Robson,
H. Leung
|
6 |
2005 |
6
🐜
|
|
🐜
|
The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
14 auth.
Kelly Coffey,
L. Rogerson,
Claudia A. Ryan-Munden,
Dhuha Alkharaif,
J. Stockley,
R. Heer,
K. Sahadevan,
Daniel J O'Neill,
Dominic Jones,
S. Darby,
...
P. Staller,
A. Mantilla,
L. Gaughan,
C. Robson
|
6 |
2013 |
6
🐜
|
|
🐜
|
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer
11 auth.
S. McCracken,
A. Ramsay,
R. Heer,
M. Mathers,
B. Jenkins,
J. Edwards,
...
C. Robson,
Rodolfo Marquez,
Philip R. Cohen,
H. Leung,
H. Leung
|
6 |
2008 |
6
🐜
|
|
🐜
|
Age-associated mitochondrial DNA mutations cause metabolic remodeling that contributes to accelerated intestinal tumorigenesis
32 auth.
Anna L. M. Smith,
Julia C. Whitehall,
Carla Bradshaw,
D. Gay,
Fiona M Robertson,
A. Blain,
G. Hudson,
A. Pyle,
D. Houghton,
M. Hunt,
James N. Sampson,
C. Stamp,
G. Mallett,
Shoba Amarnath,
J. Leslie,
...
F. Oakley,
L. Wilson,
A. Baker,
O. Russell,
Riem Johnson,
C. Richardson,
Bhavana Gupta,
I. McCallum,
S. McDonald,
S. Kelly,
J. Mathers,
R. Heer,
Robert W. Taylor,
N. Perkins,
D. Turnbull,
O. Sansom,
Laura C. Greaves
|
6 |
2020 |
6
🐜
|
|
🐢
|
A Novel Model of Urinary Tract Differentiation, Tissue Regeneration, and Disease: Reprogramming Human Prostate and Bladder Cells into Induced Pluripotent Stem Cells
15 auth.
M. Moad,
D. Pal,
A. Hepburn,
S. Williamson,
L. Wilson,
M. Lako,
L. Armstrong,
S. Hayward,
O. Franco,
J. Cates,
...
S. Fordham,
S. Przyborski,
J. Carr-wilkinson,
C. Robson,
R. Heer
|
6 |
2013 |
6
🐢
|
|
🐢
|
In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells
11 auth.
J. Blackwood,
S. Williamson,
Laura C. Greaves,
L. Wilson,
Anastasia C Rigas,
R. Sandher,
...
R. Pickard,
C. Robson,
D. Turnbull,
R. Taylor,
R. Heer
|
6 |
2011 |
6
🐢
|
|
🐬
|
High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage
R. Veeratterapillay,
R. Heer,
Mark I. Johnson,
R. Persad,
C. Bach
|
6 |
2016 |
6
🐬
|
